Public Profile

Csl

CSL Limited, commonly referred to as CSL, is a global biotechnology leader headquartered in Australia. Founded in 1916, the company has evolved significantly, establishing a strong presence in key operational regions including North America, Europe, and Asia-Pacific. Specialising in the development of innovative therapies for rare and serious diseases, CSL focuses on areas such as immunology, haematology, and respiratory health. The company is renowned for its core products, including immunoglobulins and clotting factors, which are distinguished by their high quality and efficacy. CSL's commitment to research and development has positioned it as a market leader, with notable achievements such as being consistently ranked among the top biopharmaceutical companies globally. With a rich history and a dedication to improving patient outcomes, CSL continues to set benchmarks in the biotechnology industry.

DitchCarbon Score

How does Csl's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Csl's score of 29 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.

94%

Csl's reported carbon emissions

In 2023, CSL Limited reported total carbon emissions of approximately 336,000,000 kg CO2e, comprising 113,000,000 kg CO2e from Scope 1 and 223,000,000 kg CO2e from Scope 2 emissions. The company has shown a commitment to reducing its carbon footprint, with a notable decrease in emissions from 347,000,000 kg CO2e in 2022 to the current figure. CSL has set near-term reduction targets, although it has not committed to a net-zero goal. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector and is headquartered in Australia. Its emissions data reflects a consistent effort to monitor and manage greenhouse gas emissions, particularly in Scope 1 and 2 categories, while Scope 3 emissions remain unreported in the latest disclosures. Overall, CSL's ongoing commitment to sustainability is evident through its emissions tracking and reduction initiatives, aligning with industry standards for climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
-
-
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
-
-
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
0,000,000,000
0,000,000,000
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Csl's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Csl is headquartered in AU, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Csl is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Baxter

US
Health and social work services (85)
Updated about 17 hours ago

MERCK Kommanditgesellschaft auf Aktien

DE
Research and development services (73)
Updated about 17 hours ago

Gilead Sciences

US
Research and development services (73)
Updated 5 days ago

Pfizer Limited

IN
Chemicals nec
Updated 5 days ago

Hualan Bio

CN
Chemicals nec
Updated 5 days ago

Teva Pharmaceuticals

IL
Chemicals nec
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers